Login / Signup

The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study.

Myungsun ShimWoo Jin BangCheol Young OhYong Seong LeeSeong Soo JeonHanjong AhnYoung Su JuJin Seon Cho
Published in: Journal of Korean medical science (2020)
Our complete enumeration of the Korean Pca population shows that ADT is not associated with increased risks of cardiovascular disease.
Keyphrases
  • cardiovascular disease
  • prostate cancer
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • type diabetes
  • chronic kidney disease
  • prognostic factors
  • radical prostatectomy
  • coronary artery disease